MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Circassia Pharmaceuticals PLC Company Profile (LON:CIR)

Consensus Ratings for Circassia Pharmaceuticals PLC (LON:CIR) (?)
Ratings Breakdown: 4 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 3.20)
Consensus Price Target: GBX 452.80

Analysts' Ratings History for Circassia Pharmaceuticals PLC (LON:CIR)
Show:
DateFirmActionRatingPrice TargetActions
5/25/2016Peel HuntReiterated RatingBuyGBX 509View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2016Numis Securities LtdReiterated RatingBuyGBX 565View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2016RBC CapitalReiterated RatingTop pickGBX 430View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016JPMorgan Chase & Co.Boost Price TargetOverweightGBX 390 -> GBX 410View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2016Stifel NicolausReiterated RatingBuyGBX 350View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015Canaccord GenuityReiterated RatingBuyGBX 325View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2015Shore CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015Oriel Securities LtdReiterated RatingAddGBX 320View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/28/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha